個案資料
了解個案內容與學習目標，選擇授課教師及使用課程。
Endo Pharmaceuticals (A): From LBO to ...?
內容大綱
Endo Pharmaceuticals was formed in 1997 as a leveraged buyout spin-off from DuPont Merck. In 1999, it must decide whether to do an IPO or merge with a smaller company.